# Bivalirudin vs Heparin in ECMO Patients

> **NCT03707418** · PHASE1 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Extracorporeal Membrane Oxygenation Complication

## Interventions

- **DRUG:** Heparin Sodium
- **DRUG:** Bivalirudin Injection [Angiomax]

## Key facts

- **NCT ID:** NCT03707418
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04
- **Primary completion:** 2021-06
- **Final completion:** 2021-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unable to secure funding
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03707418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03707418, "Bivalirudin vs Heparin in ECMO Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03707418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*